Californian and Korean CROs Eckert & Ziegler Vitalea Science and BioCore are to co-market complementary services in support of clinical drug development.
A new LC–MS/MS method has been developed to simultaneously quantify monoclonal antibodies in a cassette-dosing setting using rat plasma.
The Presage® ST2 Assay is to be offered by Quest Diagnostics and LabCorp following agreements with the company who market the test, Critical Diagnostics.
Identification of potential biomarkers for difficult-to-diagnose Kawasaki disease.
Robert Gerszten receives an Agilent Thought Leader Award from Agilent Technologies Inc.
Genisphere and Lankenau Institute for Medical Research collaborate in the development of targeted nanotherapeutics.